Edgestream Partners, L.P. Bausch Health Companies Inc. Transaction History

Edgestream Partners, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $2.8 Million - $5.62 Million	610,632 New	610,632 $4.21 Million
Q1 2022 May 13, 2022	SELL	$21.6 - $27.79 $1.3 Million - $1.68 Million	-60,346 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$23.0 - $29.01 $80,937 - $102,086	3,519 Added 6.19%	60,346 $1.67 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $1.42 Million - $1.71 Million	56,827 New	56,827 $1.58 Million
Q4 2020 Feb 11, 2021	SELL	$15.31 - $21.12 $1.81 Million - $2.5 Million	-118,459 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$14.88 - $20.13 $1.76 Million - $2.38 Million	118,459 New	118,459 $1.84 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Edgestream Partners, L.P. with notifications on news.